|
HERPUD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64135371960583E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.04219982538712E-11 |
| Normal-vs-Stage2 |
1.23020005293739E-09 |
| Normal-vs-Stage3 |
1.63979940737136E-13 |
| Normal-vs-Stage4 |
1.35449984561831E-10 |
| Stage1-vs-Stage2 |
1.467190E-01 |
| Stage1-vs-Stage3 |
1.801800E-02 |
| Stage1-vs-Stage4 |
7.813700E-02 |
| Stage2-vs-Stage3 |
7.859200E-01 |
| Stage2-vs-Stage4 |
8.323000E-01 |
| Stage3-vs-Stage4 |
9.740200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.63753513158372E-14 |
| Normal-vs-AfricanAmerican |
3.020000E-04 |
| Normal-vs-Asian |
1.52649999973775E-07 |
| Caucasian-vs-AfricanAmerican |
3.049000E-01 |
| Caucasian-vs-Asian |
6.571800E-01 |
| AfricanAmerican-vs-Asian |
5.635400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.03486141667508E-13 |
| Normal-vs-Female |
2.04569694517431E-12 |
| Male-vs-Female |
7.412800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.91630003374155E-09 |
| Normal-vs-Age(41-60Yrs) |
5.52891066263328E-14 |
| Normal-vs-Age(61-80Yrs) |
1.8043344596208E-12 |
| Normal-vs-Age(81-100Yrs) |
6.165500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.539200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.258900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.404800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.763600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.720600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.031800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.664210E-03 |
| Classical-VS-Follicular |
3.298100E-03 |
| Classical-VS-Other |
2.815200E-01 |
| Classical-VS-Normal |
4.64169813696458E-11 |
| Tall-VS-Follicular |
2.646400E-01 |
| Tall-VS-Other |
5.908800E-01 |
| Tall-VS-Normal |
8.05200350839641E-11 |
| Follicular-VS-Other |
9.577000E-01 |
| Follicular-VS-Normal |
3.312794483179E-11 |
| Other-VS-Normal |
1.043330E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.06181771445335E-14 |
| Normal-vs-N1 |
9.11160003003175E-09 |
| N0-vs-N1 |
7.750000E-01 |
|
|
